Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 18;145(2):1129-1135.
doi: 10.1021/jacs.2c10793. Epub 2022 Dec 28.

Modular Synthesis of Unnatural Peptides via Rh(III)-Catalyzed Diastereoselective Three-Component Carboamidation Reaction

Affiliations

Modular Synthesis of Unnatural Peptides via Rh(III)-Catalyzed Diastereoselective Three-Component Carboamidation Reaction

Christopher W Lamartina et al. J Am Chem Soc. .

Abstract

Herein we report a modular peptide ligation methodology that couples dioxazolones, arylboronic acids, and acrylamides to construct amide bonds in a diastereoselective manner under mild conditions, facilitated by Rh(III) catalysis. By converting the C-terminus of one peptide into a dioxazolone and the N-terminus of a second peptide into an acrylamide, the two pieces can be bridged by an arylboronic acid to construct unnatural phenylalanine, tyrosine, and tryptophan residues at the junction point with diastereoselectivity for their corresponding d-stereocenters. The reaction exhibits excellent functional group tolerance with a large substrate scope and is compatible with a wide array of protected amino acid residues that are utilized in Fmoc solid phase peptide synthesis. The methodology is applied to the synthesis of six diastereomeric proteasome inhibitor analogs, as well as the ligation of two 10-mer oligopeptides to construct a 21-mer polypeptide with an unnatural phenylalanine residue at the center.

PubMed Disclaimer

Figures

Scheme 1.
Scheme 1.
Transition metal catalyzed methods of unnatural amino acid incorporation in peptides
Scheme 2.
Scheme 2.. Boronic acid scope
All yields and dr reported are isolated, with the crude dr in parentheses. All reactions conducted on 0.1 mmol scale. a0.033 mmol scale.
Scheme 3.
Scheme 3.. Dioxazolone scope (top) and acrylamide scope (bottom)
All yields and dr reported are isolated, with the crude dr in parentheses. a0.1 mmol scale. b0.033 mmol scale. c0.01 mmol scale. d0.6 M conc. e0.2 M conc. f0.1 M conc. g0.067 M conc. More dilute concentrations are to ensure full homogeneity of less soluble substrates.
Scheme 4.
Scheme 4.
Proposed catalytic cycle of three-component carboamidation reaction
Scheme 5.
Scheme 5.. Synthesis of proteasome inhibitor analogs
Crude dr of each reaction is in parentheses. All reactions conducted on 0.033 mmol scale.
Scheme 6.
Scheme 6.. Synthesis of 21-mer unnatural peptide
Reaction conducted on 0.01 mmol scale. Yield and diastereoselectivity is of the isolated compound.

Similar articles

Cited by

References

    1. Li Petri G; Di Martino S; De Rosa M Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors. J. Med. Chem 2022, 65 (11), 7438–7475. - PubMed
    1. Fosgerau K; Hoffmann T Peptide Therapeutics: Current Status and Future Directions. Drug Discov. 2015, 20 (1), 122–128. - PubMed
    1. Wang L; Wang N; Zhang W; Cheng X; Yan Z; Shao G; Wang X; Wang R; Fu C Therapeutic Peptides: Current Applications and Future Directions. Signal Transduct. Target. Ther 2022, 7 (1), 1–27. - PMC - PubMed
    1. Qvit N; Rubin SJS; Urban TJ; Mochly-Rosen D; Gross ER Peptidomimetic Therapeutics: Scientific Approaches and Opportunities. Drug Discov. 2017, 22 (2), 454–462. - PMC - PubMed
    1. Ding Y; Ting JP; Liu J; Al-Azzam S; Pandya P; Afshar S Impact of Non-Proteinogenic Amino Acids in the Discovery and Development of Peptide Therapeutics. Amino Acids 2020, 52 (9), 1207–1226. - PMC - PubMed

Publication types